Ignite Creation Date:
2024-05-06 @ 10:13 AM
Last Modification Date:
2024-10-26 @ 12:26 PM
Study NCT ID:
NCT03193853
Status:
COMPLETED
Last Update Posted:
2023-08-07
First Post:
2017-06-09
Brief Title:
TAK-228 and TAK-117 Followed by Cisplatin and Nab Paclitaxel for Metastatic Triple Negative Breast Cancer
Sponsor:
Joyce OShaughnessy
Organization:
Baylor Research Institute
Organization Data
Organization:
Baylor Research Institute
Class:
OTHER
Study ID:
017- 113
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Joyce OShaughnessy
Lead Sponsor Class:
OTHER
Responsible Party:
Joyce OShaughnessy
Responsible Party Title:
Medical OncologistMedical Director
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Baylor Research Institute
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Takeda | INDUSTRY |